Page 108 - Memora anual Fundación CIEN 2017
P. 108
Valentina González from the Department of Neuro- Global Summit on Research in Neurodegenerative
pathology; and Jaime Gómez and Linda Zhang Diseases, which was held on 21, 22 and 23 Septem-
from the Department of Neuroimaging. ber 2017 in Lisbon under the chairmanship of H.M.
Queen Sofia, the parties involved are committed to
In addition, with the additional participation of the maintain a continuous and active collaboration in
State Reference Center for the Care of Patients with the future with the intention of promoting the kno-
Alzheimer's Disease and other Dementias) of the wledge of both countries in a field as unknown as
Spain’s Ministry of Health, Services and Equality, on that of neuroscience. In this regard, the Summit has
September 18-19 the welfare and social health pro- highlighted the close links of collaboration between
gram was also carried out, which was attended by institutions and scientists from both countries, with the
experts such as Takanori Shibata, an expert in artifi- aim of promoting a joint European policy of research
cial intelligence applied to the treatment of neuro- and treatment of neurodegenerative diseases, a
degenerative diseases, and Vladimir Hachinski, a problem of costly economic and social consequen-
professor at the University of Western Ontario and ces in countries with aging populations.
one of the world's leading dementia authorities,
both delivered keynote lectures. Also participating, 5.5.2. Alzheimer's Association
among others, were Mercè Boada, founder and me-
dical director of the ACE Foundation in Barcelona The Alzheimer's Association is a non-profit organiza-
and specialist in early diagnosis of AD, and Pablo tion that focuses on the care and support of patients
Martínez-Lage, Director of Neurology of the CITA with Alzheimer's disease, and which also finances re-
Foundation (San Sebastian). search projects on this field through competitive
calls. During 2017, CIEN Foundation researchers in
In short, this event has constituted an excellent me- collaboration with CIBERNED and the Technical Uni-
eting point for some of the leading national and in- versity of Madrid have received funding from the Alz-
ternational experts in neurodegenerative diseases, heimer's Association to carry out two research
allowing to share knowledge, working methodolo- projects:
gies, new advances and discoveries, in a field in
which international cooperation and between insti- 1. A multicenter, randomized, double-blind,
tutions is decisive for obtaining optimal results in re- placebo-controlled, 4-arm, 26 week parallel-
search. group study to evaluate the safety, tolerability
and anti-inflammatory effect of three
▄▀ 5.5. Other activities of international oromucosal doses of Sativex® in patients with
cooperation mild cognitive impairment of Alzheimer type
or early Alzheimer dementia (Sat-CIEN-02).
5.5.1. Collaboration with the Principal Investigator: Dr. Isidro Ferrer
Champalimaud Foundation (CIBERNED)
The CIEN Foundation continues to actively partner During 2017 the activities of this clinical trial were
with the Champalimaud Foundation in accordance continued, included in an open and competitive
with the collaboration agreement signed in Decem- call of the U.S. Alzheimer's Association, which was
ber 2015. In addition to the joint organization of the approved and funded by it to be carried out in
Spain during the period of Sept-2016 to Oct-2018.
CIEN Foundation Annual Report 2017 / 108
